Biotron have had 6 months to plan and prepare for funding and to attract a partner/commercial deal.
It is no suprise to see an association such as this so soon after Biotron announced on Monday it had received guidance from the FDA to progress BIT225 to a phase 2 trial for C19.
I am not expecting to wait long for further announcements regarding funding and wouldn't be suprised if a commercial deal materializes from here.
With the HIV trials progressing in the background and now a phase 2 C19 human trial, with guidance from the FDA, there is too much to like with BIT 225 at the minute.
It would seem some manipulation happening with the SP at the minute however the market can't ignore what Biotron have going on for too long.
GLTAH
Biotron have had 6 months to plan and prepare for funding and to...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.72M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.4¢ | 5.2¢ | $2.393K | 44.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19600 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 188178 | 2 |
View Market Depth
| Last trade - 15.15pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.4¢ |
Change
0.000 ( 3.85 %) |
||||
| Open | High | Low | Volume | ||
| 5.4¢ | 5.4¢ | 5.2¢ | 120722 | ||
| Last updated 15.15pm 03/05/2024 ? | |||||
| BIT (ASX) Chart |